UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 76 filers reported holding UROGEN PHARMA LTD in Q1 2019. The put-call ratio across all filers is 0.32 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $148,542 | +17.1% | 16,076 | +12.4% | 0.00% | – |
| Q4 2022 | $126,841 | -78.6% | 14,300 | -13.2% | 0.00% | -100.0% |
| Q2 2019 | $592,000 | -91.0% | 16,484 | -90.8% | 0.00% | -92.0% |
| Q1 2019 | $6,612,000 | +28.2% | 178,996 | +49.5% | 0.02% | +8.7% |
| Q4 2018 | $5,156,000 | +2.4% | 119,736 | +12.4% | 0.02% | +27.8% |
| Q3 2018 | $5,033,000 | +378.9% | 106,548 | +404.2% | 0.02% | +350.0% |
| Q2 2018 | $1,051,000 | – | 21,132 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 789,297 | $39,275,000 | 60.44% |
| Wildcat Capital Management, LLC | 251,459 | $12,513,000 | 9.57% |
| Consonance Capital Management LP | 1,487,491 | $74,018,000 | 4.77% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,499,870 | $124,394,000 | 3.53% |
| MEITAV INVESTMENT HOUSE LTD | 509,355 | $29,967,000 | 1.34% |
| DSAM Partners (London) Ltd | 127,588 | $6,349,000 | 1.28% |
| SHIKIAR ASSET MANAGEMENT INC | 48,125 | $2,395,000 | 1.00% |
| BANK HAPOALIM BM | 67,125 | $3,340,000 | 0.91% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 331,900 | $16,515,000 | 0.55% |
| Clal Insurance Enterprises Holdings Ltd | 310,000 | $15,426,000 | 0.40% |